A well-produced Certificate of Analysis for a research peptide includes at minimum two analytical results: an HPLC purity figure and mass spectrometry identity confirmation. Most researchers know that higher purity is better and that a matching molecular weight is a good sign — but the actual mechanics of what each test measures, and crucially what each test cannot tell you, are less commonly understood.
This matters more than it might seem. The two tests answer fundamentally different questions, and neither is a substitute for the other.
What HPLC Actually Measures
High-performance liquid chromatography (HPLC) works by passing a dissolved sample through a column packed with a stationary phase material, while a mobile phase (solvent) carries the sample components through at varying speeds depending on their chemical properties — primarily their hydrophobicity for the reversed-phase HPLC used in peptide analysis.
Different components of the sample travel through the column at different rates and emerge (elute) at different times. A UV detector records each component as it exits, producing a chromatogram — a graph of UV absorbance over time. Each peak on the chromatogram represents a distinct component, and the area of each peak is proportional to its concentration.
What this tells you: HPLC purity is calculated as the target peptide’s peak area divided by the total area of all detected UV-absorbing peaks. A purity of 98.5% means that 98.5% of the UV-absorbing material detected in the sample corresponds to the target peptide, with the remaining 1.5% being other organic compounds — typically synthesis-related impurities such as deletion sequences, truncated fragments, or side-reaction products.
What HPLC doesn’t tell you:
- Whether the main peak is actually the peptide you ordered (it tells you a dominant UV-absorbing compound is present, not its identity)
- The absolute quantity of peptide per vial (purity is a ratio, not a mass measurement)
- The presence of non-UV-absorbing contaminants such as inorganic salts, water, or counter-ions — which is why HPLC purity and net peptide content are different figures
What Mass Spectrometry Actually Measures
Mass spectrometry works differently. It doesn’t separate compounds by their physical properties — it measures their molecular mass. The sample is ionised (given a charge), then passed through a magnetic field. Different masses travel through this field at different rates, arriving at the detector at different times, producing a mass spectrum.
For peptide analysis, electrospray ionisation mass spectrometry (ESI-MS) or MALDI-TOF are the most common methods. Both produce a spectrum showing the mass-to-charge ratio (m/z) of ions detected in the sample.
What this tells you: By comparing the observed mass against the theoretical molecular weight calculated from the peptide’s amino acid sequence, mass spectrometry confirms (or refutes) that the compound’s molecular weight matches what the target peptide should weigh. A matching observed mass is identity confirmation — it tells you that the compound could be the peptide it’s labelled as.
What mass spectrometry doesn’t tell you:
- How pure the sample is — a sample could be 70% pure and still produce a matching mass spectrum, because MS will detect the target compound even amid substantial impurities
- The precise quantity of peptide present
- Whether isomers or closely related compounds with the same molecular weight might be present (though this is relatively uncommon in standard peptide analysis)
Why You Need Both — And Neither Alone is Sufficient
This is the core of why a CoA should include both tests, not one or the other.
HPLC without mass spectrometry: You know the sample contains a dominant compound at high purity, but you can’t confirm from HPLC alone that this dominant compound is actually the peptide you ordered. HPLC measures relative proportions of UV-absorbing materials — it doesn’t identify them.
Mass spectrometry without HPLC: You can confirm a compound with the right molecular weight is present, but you have no information about how much of the sample it represents. A sample could theoretically pass an MS identity check while being substantially impure.
Together: HPLC tells you that approximately 98.5% of the UV-absorbing material is a single dominant compound. Mass spectrometry confirms that dominant compound has the molecular weight corresponding to the target peptide. Together, they provide meaningful evidence that you have the peptide you ordered, at the stated purity.
A Third Figure: Net Peptide Content
Neither HPLC purity nor MS identity confirmation tells you about the non-peptide material in the vial — counter-ions, residual solvents, moisture, and excipients that contribute to the total vial weight without being active peptide. This is what net peptide content measures.
Net peptide content is typically determined by amino acid analysis or by accounting for known counter-ion content. A vial stated as 5mg total weight with 85% net peptide content contains approximately 4.25mg of actual active peptide — meaningfully different from 5mg for the purposes of accurate concentration calculations.
Some CoAs include this figure; many do not. Where it’s absent, concentration calculations based on stated vial weight will be slightly higher than the actual peptide concentration in solution. For most exploratory research this is a minor consideration, but for quantitative work requiring precise concentrations, net peptide content matters.
How to Apply This When Reading a CoA
When you receive a CoA, work through these checks in order:
- Confirm the batch number matches your vial. A mismatched batch number means the CoA has no relevance to your specific material.
- Check the testing laboratory is named and independently identifiable. Third-party testing from a named, verifiable laboratory is more reliable than in-house testing.
- Check the HPLC purity figure and, where included, the chromatogram. The main peak should be dominant with minimal secondary peaks. A purity of ≥98% is the standard threshold for most research applications.
- Check the MS identity confirmation. The observed mass should match the theoretical molecular weight for your peptide within the method’s margin of error (typically ±1 Da for ESI-MS on compounds up to a few thousand Da).
- Note whether net peptide content is provided. If it is, use that figure for concentration calculations rather than the total stated vial weight.
For a full walkthrough of every section of a typical peptide CoA, see our dedicated Certificate of Analysis interpretation guide, which covers what each field means, what good data looks like, and what red flags to watch for.
Summary
| Test | What it measures | What it confirms | What it doesn’t tell you |
|---|---|---|---|
| HPLC purity | Proportion of UV-absorbing material attributable to the target peptide | Purity relative to synthesis impurities | Identity; absolute quantity; non-UV-absorbing content |
| Mass spectrometry | Molecular weight of detected compounds | Identity (compound has the expected molecular weight) | Purity; absolute quantity |
| Net peptide content | Proportion of total vial weight that is active peptide | Actual active peptide mass per vial | N/A — complements both of the above |
A credible CoA includes all three, or at minimum the first two, from an independently verifiable third-party laboratory on a batch-specific basis.
Peptician provides independently tested, batch-specific Certificates of Analysis with every product. Browse our catalogue or visit our Research Library for further reading.
This post is provided for educational and laboratory research reference purposes only.